Peritoneal Tumor DNA as a Prognostic Biomarker in Pancreatic Cancer: A Systematic Review and Meta-Analysis.

IF 1.7 4区医学 Q3 GASTROENTEROLOGY & HEPATOLOGY

Pancreas Pub Date : 2024-11-25 DOI:10.1097/MPA.0000000000002437

Mariana Macambira Noronha, Luís Felipe Leite da Silva, Pedro C A Reis, João Evangelista Ponte Conrado, Thais Baccili Cury Megid, Erick F Saldanha

引用次数: 0

查看原文本刊更多论文

腹膜肿瘤 DNA 作为胰腺癌的预后生物标记物：系统回顾与元分析》。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pancreas 医学-胃肠肝病学

CiteScore

4.70

自引率

3.40%

发文量

289

审稿时长

1 months

期刊介绍： Pancreas provides a central forum for communication of original works involving both basic and clinical research on the exocrine and endocrine pancreas and their interrelationships and consequences in disease states. This multidisciplinary, international journal covers the whole spectrum of basic sciences, etiology, prevention, pathophysiology, diagnosis, and surgical and medical management of pancreatic diseases, including cancer.